AFFINITY INVESTMENT ADVISORS, LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1520601
NEWPORT BEACH, CA
Position in BMY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,760,694
+$927,970 QoQ
Shares Held
30,557
+122.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#894
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AFFINITY INVESTMENT ADVISORS, LLC holds $11,731,822 across 9 Drug Manufacturers - General names. BMY ranks #4 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,898 | $2,239,092 | |
| 2 | JNJ |
Johnson & Johnson
|
8,462 | $2,149,094 | |
| 3 | PFE |
Pfizer Inc
|
79,689 | $1,918,911 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
30,557 | $1,760,694 | |
| 5 | AMGN |
Amgen Inc
|
4,328 | $1,567,255 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,172 | $921,602 | |
| 7 | LLY |
ELI LILLY & Co
|
360 | $431,794 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,040 | $384,073 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,760,694 | 30,557 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $832,724 | 13,730 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $729,916 | 13,532 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $616,156 | 13,662 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $649,078 | 14,022 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $883,867 | 14,492 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $827,133 | 14,624 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $941,254 | 18,192 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $750,654 | 18,075 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $988,233 | 18,223 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $937,177 | 18,265 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,184,306 | 20,405 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,342,182 | 20,988 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,796,653 | 25,922 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $3,059,026 | 42,516 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,022,462 | 42,516 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,316,390 | 43,070 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $3,177,973 | 43,516 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $2,732,052 | 43,818 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,834,716 | 47,908 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,224,532 | 48,257 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,240,252 | 67,167 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,265,617 | 68,767 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,315,437 | 71,578 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,988,933 | 67,839 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,283,897 | 76,855 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||